Rejected at 3:44 a.m. Nov, 11, 2024 ] by IantheBFG
Bulk Suggestion Bulk ID: IantheBFG/10.29.24-02:51PM
Author: IantheBFG
Related Note: 1505673750546
Rationale for change

Cefotaxime is preferred in children <1 month due to risk of hyperbilirubinemia with ceftriaxone
Source: UWorld - Step 2 3758

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::07_Perinatal_Infections::Extra #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::02_Macrolides_[Old_Version] #AK_Step2_v12::#NBME::Form11 #AK_Step2_v12::#UWorld::COMLEX::100553 #AK_Step2_v12::!Shelf::Peds::no_dupes #PANCE::EENT::Eye #AK_Step1_v12::#B&B::17_Ophthalmology::01_General::02_Eye_Disorders::Extra #AK_Step2_v12::#B&B::12_Pediatrics::01_Newborns::02_Newborn_Nursery #PANCE::EOR::PEDS #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #AK_Step2_v12::#AMBOSS::4Q03wf #AK_Step2_v12::#UWorld::Step::3758 #AK_Step2_v12::#Resources_by_rotation::Peds::ome::peds_ophtho #AK_Step2_v12::#AMBOSS::1Q02Ef #AK_Step1_v12::#Bootcamp::Microbiology::16_Atypical_Bacteria::02_Chlamydia_Trachomatis_Serotypes_and_Disease_Variants #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::05_Other_Gram_Negatives::Extra #AK_Step2_v12::#AMBOSS::FHagHN #AK_Step2_v12::#SketchyPeds::09_Infectious_Diseases::02_Neurologic_&_Eye_Infections::04_Neonatal_Conjunctivitis_DDx #AK_Step2_v12::Original_decks::Dorian::peds::ome::peds_ophtho #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::16_Macrolides #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Neonatal_Conjunctivitis #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Neurology::Neonatal_Conjunctivitis #AK_Step1_v12::#OME::Clinical::Pediatrics::Pediatric_Surgery::Pediatric_Ophthalmology #AK_Step2_v12::#FirstAid::12_Pediatrics::08_Pediatric_Infectious_Disease::06_Ocular_Infections_of_the_Neonate #PANCE::EOR::Family_med #AK_Step2_v12::#OME::03_Pediatrics::22_Ophthalmology #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::18_Macrolides #AK_Step1_v12::#AMBOSS::o_006i #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::14_Macrolides #AK_Step2_v12::#FirstAid::09_Neuro::17_Ophthalmology::08_Conjunctivitis::Extra #AK_Step1_v12::#Pixorize::04_Microbiology::05_Bacteria-Gram_Negative::02_Neisseria_gonorrhoeae #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs